Efficacy of Long-term Effect and Repeat Intraarticular Botulinum toxin in Patients with Painful Total Joint Arthroplasty: A Retrospective Study
Journal Title: Journal of Advances in Medicine and Medical Research - Year 2014, Vol 4, Issue 1
Abstract
Objective: Based on recent success of intra-articular (IA) Botulinum neurotoxin type A (BoNT/A; OnabotulinumtoxinA) in patients with osteoarthritis, we examined if repeat IA-BoNT/A is an effective antinociceptive in patients with refractory arthroplasty pain. Methods: 11 patients with refractory chronic arthroplasty joint pain without any evidence of infection or prosthesis loosening were referred by orthopedic surgeons. After discussion of off-label use, each patient underwent IA injection of BoNT/A, repeated based on return of pain on numeric rating scale (NRS) and functional limitation on composite validated scales, Western Ontario McMaster Osteoarthritis index (WOMAC) or Shoulder Pain and Disability (SPADI). Results: 11 patients (10 men, 1 woman) with 14 painful arthroplasty joints (3 bilateral; 12 knee and 2 shoulder) underwent ≥1 IA-BoNT/A injections (8 joints injected once, one joint injected twice only, five joints injected thrice) with doses ranging 100-300 units. Mean age was 68 years (standard deviation, 12) and follow-up ranged 1-28 months. Clinically meaningful reduction of 2-units in pain severity and really meaningful reduction in pain severity (50% reduction) were reported by 6/11 patients (6/13 joints) and 3/11 patients (3/13 joints), respectively, 1 month after the first IA-BoNT/A (100-units each). Significant improvements were noted in composite functional scales (WOMAC/SPADI). Pain relief was sustained at 3-4 month follow-up and was reproducible in those who received repeat injections. No significant adverse events were seen in any patients. Conclusions: A single intra-articular injection of BoNT/A improved pain and function in patients with chronic, refractory painful knee or shoulder arthroplasty, which sustained with repeat injections. Patients, who were refractory to the first injection, did not respond to subsequent injections of higher dose of IA-BoNT/A.
Authors and Affiliations
Jasvinder A. Singh
Keywords
Related Articles
- EP ID EP348511
- DOI 10.9734/BJMMR/2014/4897
- Views 81
- Downloads 0
The Role of Graduated Drivers' Licensing on Incidence and Severity of Road Traffic Injuries in Iran
Aims: This study investigated the role of graduated drivers licensing, implemented by the Traffic Police of Iran, on reducing the severity and incidence of road traffic injuries. Study Design: It was an evaluation of the...
Management of Ankylogossia by Frenectomy- A Case Report
Background: The tongue is an important oral structure that is responsible for speech, swallowing, positioning of the teeth, and taste. Ankyloglossia or “tongue-tie” is due to an abnormally thick and shortened lingual fre...
Effectiveness of Educational Intervention on Jordanian Nurses’ Knowledge and Attitude Regarding Pain Management
Aim: Although guidelines and pharmacological interventions exist to manage pain, poor assessment and under-medication are prevalent. It was reported that inadequacy of pain management can be due to nurses’ lack of knowle...
Relapse of Cutaneous Fungal Infection in Healthy Individuals - A Rising Concern
Background: Superficial fungal infections are among the most common skin diseases, affecting millions of people throughout the world. These infections, which occur in both healthy and immunocompromised persons, are cause...
Outbreaks of a Presumed Infectious Agent Associated with Changes in Fertility, Stillbirth, Congenital Abnormalities and the Gender Ratio at Birth
Aims: To investigate changes in the gender ratio (M/F) at birth, fertility and stillbirth rates in England and Wales. Study Design: Analysis of average GR (1974-2010) for 570 UK local government areas. Re-analysis of ave...